![Ilse Roodink](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Ilse Roodink formerly worked at ImmunoPrecise Antibodies (Europe) BV, as Scientific Director and MindWalk Holdings Corp., as Chief Scientific Officer from 2021 to 2025.
Dr. Roodink received her undergraduate degree, graduate degree, and doctorate degree from Radboud University Nijmegen.
Eerdere bekende functies van Ilse Roodink
| Bedrijven | Functie | Einde |
|---|---|---|
| MINDWALK HOLDINGS CORP. | Hoofd Techniek/Wetenschap/O&O | 06-08-2025 |
Immunoprecise Antibodies (Europe) BV
 Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in antibiotics | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Ilse Roodink
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Radboud University Nijmegen
 Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmunoPrecise Antibodies Ltd.
 ImmunoPrecise Antibodies Ltd. BiotechnologyHealth Technology Operates as AI-driven biotherapeutic research and technology firm that develops & discovers antibodies | Health Technology |
Immunoprecise Antibodies (Europe) BV
Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in antibiotics | Health Technology |
